Milestone scientific reports revenue of $2.2 million and provides business update for the first quarter of 2025

Roseland, n.j., may 15, 2025 (globe newswire) -- milestone scientific inc. (nyse: mlss), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provided a business update and reported financial results for the first quarter ended march 31, 2025.
MLSS Ratings Summary
MLSS Quant Ranking